<DOC>
	<DOC>NCT00965887</DOC>
	<brief_summary>This study will evaluate the bioequivalence of two solid dose formulations of MK0974.</brief_summary>
	<brief_title>Bioequivalence of Two Tablet Forms of MK0974 (0974-045)</brief_title>
	<detailed_description />
	<criteria>Subject is in good health Subject is a nonsmoker Subject is willing to comply with the study restrictions Subject has a history of stroke, chronic seizures, or major neurological disorder Subject has a history of cancer Subject is a nursing mother Subject has or has a history of any disease or condition that might make participation in the study unsafe or that might confound the results of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>